论文部分内容阅读
目的研究分析贝复剂配合美宝烧伤膏治疗糖尿病足患者的疗效.方法将56例糖尿病足患者随机分为研究组和对照组各28例.对照组仅给予基础治疗和贝复剂,研究组在上述治疗基础上加用美宝烧伤膏治疗.对两组患者的溃疡治愈率与治愈时间进行比较.结果研究组治愈率为89.28%,对照组为82.14%,两组治愈率比较.差异无统计学意义(P>0.05).研究组患者的愈合时间为(31.54±10.33)d,对照组为(45.42±15.42)d.研究组相比对照组明显缩短.差异有统计学意义(P<0.05).结论使用美宝湿润烧伤膏的同时联合使用重组牛碱性成纤维细胞成长因子治疗糖尿病足.可以取得非常显著的治疗效果.存在明显的临床治疗价值。
Objective To study the curative effect of Beifuji combined with MEBO in the treatment of diabetic foot.Methods 56 cases of diabetic foot were randomly divided into study group and control group, 28 cases in each group.The control group was given only basic treatment and Beifufen, On the basis of the above treatment, MEBO ointment was used to treat the ulcer in the two groups.Results The cure rate was 89.28% in the study group and 82.14% in the control group, and the difference was not significant (31.54 ± 10.33) d in the study group and (45.42 ± 15.42) days in the control group.The study group was significantly shorter than the control group, the difference was statistically significant (P <0.05) 0.05) .Conclusion The use of MEBO MEBO in combination with recombinant bovine basic fibroblast growth factor in the treatment of diabetic foot can achieve a very significant therapeutic effect, and there is a clear clinical value.